Patient-reported outcomes supporting anticancer product approvals.

Abstract

In 2006, the US Food and Drug Administration (FDA) published draft guidance to provide recommendations for development, validation, implementation, and interpretation of patient-reported outcome (PRO) measures that can support treatment benefit claims in product labeling. Here, we summarize and discuss FDA approvals of anticancer products in the context of… (More)

Topics

Cite this paper

@article{Rock2007PatientreportedOS, title={Patient-reported outcomes supporting anticancer product approvals.}, author={Edwin P. Rock and Dianne L Kennedy and Melissa H Furness and William F Pierce and Richard Pazdur and Laurie B. Burke}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2007}, volume={25 32}, pages={5094-9} }